LIVEWIRE ERGOGENICS, INC. UNVEILS NEW CANNABIS SPECIFIC STRATEGY TO
ACCELERATE GROWTH AND ENHANCE VALUE
Anaheim, CA -- July 21, 2017 -- InvestorsHub NewWire
-- LiveWire Ergogenics, Inc. (OTC
PINK: LVVV), a company focused on research partnerships,
product development and commercialization of cannabinoid-based
products, today provides a brief outline of its most current
developments and the progression of its core business strategies.
The company is also proud to announce its new branding and
corporate website located at www.LiveWireErgogenics.com.
We are confident that the strategy presented today is the best
way to capture momentum in the cannabis market, while increasing
value for our shareholders. Each initiative laid out below
represent solid blocks in a strong foundation that allows us to
build a company with clear direction and focus, said LiveWire
Ergogenics CEO Bill Hodson.
Current Filing Status
The Company expects to have its Financial Reports for Q1 2017
completed and posted within the next several days. The posting of
this quarter will bring the company to a current status on OTC
Markets Pink and the Stop Sign will be subsequently removed. The
Companys management will assure that all future flings will be made
accordingly to maintain a current status.
Claim a Cannabis Market Stake
LiveWire has assembled a team of innovators to aggressively
proceed with research and development to capture market share. The
Company has entered into several strategic alliances and business
consulting agreements with horticulturists, extractors,
distributors, laboratories, branding agencies and body care
specialists. LiveWire intends to utilize the wealth of the teams
experience to acquire and/or develop new product offerings by way
of this talented network of professionals in its quest for
breakthrough success.
It Starts With the Clone
Our experts have over 25 years of combined experience in this
fascinating field and have assembled a massive genetics library,
now available to LiveWire. This specialty has high barriers to
entry when considering the scientific knowledge required to
cultivate and propagate plants, and to understand the complex
techniques to study and produce new generations of desirable
strains. The Company understands new technologies are rapidly
approaching, and exploring new advances in cloning techniques such
as tissue culture cultivation, is paramount. The near-term plan is
to support and guide the efforts of our experts into a legal,
profitable and sustainable business model with a long-term goal of
expanding nationally.
Continues With Research
Livewire is planning to commence with research studies to
explore the application of cannabinoid-based products to target
specific ailments or conditions with a large sufferer population.
These small research studies are designed to document safety,
dosage and efficacy of various combinations of CBD/THC and terpene
profiles. The Company has established two independent research
teams with highly recognized and published experts in their
respective fields. In addition to these projects, LiveWire has
begun development for products in the sports and cosmetics markets.
Livewires topical creams currently being tested are infused with
different dosage combinations of fragrances and herbs along with
THC and CBD, and are being developed for licensing. Additional
research groups from several disciplines are currently being
assembled.
Sustaining the Edible Market
LiveWire has been in the energy chew business for over eight
years, and we will continue to sell our existing line, as well as a
new all-natural line of caffeinated bite-sized energy chews. In
addition, the company is exploring the utilization of these chews
as a dosing supplement for medical and recreational CBD and THC.
Our proprietary cold manufacturing process makes the chew matrix a
perfect medium for edibles where the integrity of the ingredients
is of high importance.
LiveWires Proprietary Verification System
A credible certification process is crucial in the high-growth
and unruly medical cannabis industry. LiveWire has developed a
proprietary 7xPure Compliance & Dosage Verification System. The
7xPure system is an assembled set of verified documents pertaining
to compliance and dosage claims and the assignment of a lot-code
relating to the sum of seven highly scrutinized parts. In order for
a product to receive the 7xPure Verification Seal, it must prove
dosage claims, label claims, manufacturing good practices,
microbiological and residual solvent testing and much more. All
products produced by LiveWire will meet the criteria necessary to
display the 7xPure verification seal. The company will also market
its 7xPure Verification System to all companies in the industry,
aiming to make it the Gold Standard in the industry for the benefit
of all consumers.
Stacking the Board
The Company will expand its Board of Directors and Advisory
Board beyond the scope of the current participation research
experts. It is currently in discussion with experts in the cannabis
industry, as well as doctors, bio-chemists, real estate, legal, and
financial leaders. Our intent is to have world-class experts in
various fields in which their knowledge and experience will be one
of the driving factors for future success.
Communicating its Message
LiveWire will provide transparency and consistency with in-depth
shareholder communications. The Company is committed to frequently
updating the public about its new and material developments along
with maintaining all required filings on OTC Markets Pink.
In addition to the companys required communications, LiveWire
has entered into a consulting agreement with a renowned financial
research firm to prepare an in-depth research report for public
dissemination, once all OTC filings have been brought current.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV)
is focused on identifying and monetizing current and future trends
in the health and wellness industry. This will be accomplished by
way of research partnerships for specific ailments, cloning of
cannabis strains to produce positive medicinal results, dosing
verification of zero pesticide products for quality brands,
development and commercialization of cannabinoid based products and
services. The team at LiveWire Ergogenics is committed to
developing great products and generate innovative ideas for the
future of the company and the industry.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements.
Forward-looking statements may include, without limitation,
financial projections, statements regarding the plans and
objectives of management for future operations, the development,
regulatory approvals and commercialization of the Companys
products, or any of the Companys other proposed products, systems
or services.
Such forward-looking statements are not meant to predict or
guarantee actual results, performance, events or circumstances and
actual events may differ considerably. Factors that may cause
actual results to differ materially from any projections may
include, without limitation, the Companys inability to obtain
additional financing, delays in the development of its products,
the impact of significant government regulation in the cannabis
industry, existing or increased competition, results of arbitration
and litigation, stock volatility and illiquidity, and the Companys
failure in general to implement the Companys business plans or
strategies. The Company assumes no obligation to update any
forward-looking statements to reflect any event or circumstance
that may arise after the date of this release.
LIVEWIRE ERGOGENICS INC.
1600 North Kraemer Blvd.
Anaheim, CA 92806
714-740-5144
www.livewireergogenics.com
info@livewireergogenics.com